CorMedix Therapeutics to Participate in Wells Fargo Healthcare Conference

PARSIPPANY, N.J., Sept. 01, 2026 /CourierPR/ -- CorMedix Therapeutics, a biopharmaceutical company dedicated to developing and commercializing therapeutic products for life-threatening diseases, will participate in the upcoming Wells Fargo 21st Annual Healthcare Conference. The event, set to take place from September 8 to 10, 2026, in Boston, will feature a fireside chat and investor meetings with the company’s senior management.

Attendees of the conference can expect to hear insights and updates from CorMedix’s executives during the fireside chat. Following the event, a replay of the discussion will be accessible on the company’s investor relations page at www.cormedix.com.

CorMedix Therapeutics focuses on the prevention and treatment of severe conditions and diseases within the United States. The company has established a robust infrastructure, including field-based medical and commercial teams, to support the sale and marketing of its products in hospital, clinic, and infusion center settings.

For those interested in learning more about CorMedix’s initiatives and products, the company’s website offers detailed information at www.cormedix.com.